PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. (Record no. 26946135)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02322 a2200637 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517142529.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201806s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1557-3265 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1158/1078-0432.CCR-16-2601 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Melaiu, Ombretta |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180619 |
245 00 - TITLE STATEMENT | |
Title | PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Clinical cancer research : an official journal of the American Association for Cancer Research |
Date of publication, distribution, etc. | Aug 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 4462-4472 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antigens, CD |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Azepines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | B7-H1 Antigen |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomarkers, Tumor |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Child |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Child, Preschool |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression Regulation, Neoplastic |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genes, MHC Class I |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infant |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphocytes, Tumor-Infiltrating |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Molecular Targeted Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | N-Myc Proto-Oncogene Protein |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neuroblastoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Programmed Cell Death 1 Receptor |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins c-myc |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Triazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphocyte Activation Gene 3 Protein |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mina, Marco |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chierici, Marco |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Boldrini, Renata |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jurman, Giuseppe |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Romania, Paolo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | D'Alicandro, Valerio |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Benedetti, Maria C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Castellano, Aurora |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liu, Tao |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Furlanello, Cesare |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Locatelli, Franco |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fruci, Doriana |
773 0# - HOST ITEM ENTRY | |
Title | Clinical cancer research : an official journal of the American Association for Cancer Research |
Related parts | vol. 23 |
-- | no. 15 |
-- | p. 4462-4472 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1158/1078-0432.CCR-16-2601">https://doi.org/10.1158/1078-0432.CCR-16-2601</a> |
Public note | Available from publisher's website |
No items available.